News Release

Samuel Huang, M.D., receives Pfizer/ACMG Foundation Next Generation Award

Grant and Award Announcement

American College of Medical Genetics and Genomics

Samuel Huang, MD of the Marshfield Clinic in Wisconsin is the recipient of the Pfizer/ACMG Foundation Next Generation Clinical Genetics and Genomics Residency Fellowship Award, announced at the 2019 ACMG Annual Clinical Genetics Meeting in Seattle, WA.

The objective of this fellowship is to provide an in-depth clinical research training experience at a premier medical center with expertise and significant clinical volume in the area of biochemical genetics, including lysosomal storage diseases, as well as in therapeutics and clinical trials involving patients with these and other metabolic diseases and, thereby, to increase the number of medical geneticists with interest, knowledge, and expertise in this area.

This Award grants $75,000 per year to the recipients, via their respective institutions, selected by the ACMG Foundation through a competitive process and will provide a two-year sponsorship for the trainee's clinical genetics subspecialty training in translational genomics following residency.

Dr. Samuel Huang is completing his Pediatric Residency at the Marshfield Clinic. He participated in research projects in ophthalmic genetics and pharmacogenetics. Dr. Huang is also a member of the Wisconsin Genetics Advisory Committee (GAC). The purpose of the Wisconsin GAC is to advise the Wisconsin Children and Youth with Special Health Care Needs Program and its Genetics Systems Integration Hub, and guide efforts to strengthen the pediatric genetic infrastructure in Wisconsin.

Dr. Huang is fascinated by the depth and breadth of medical genetics and genomics and said, "I am extremely grateful for this trainee award which will allow me to continue my residency training at the University of Washington. Improving patient care can be affected by details of technique at the bench up to big-picture public health genomics and policy changes. I am excited to continue my education at a place where I can find mentorship in all of these areas."

"We are delighted to be able to partner with Pfizer in awarding the Pfizer/ACMG Foundation Clinical Genetics Combined Residency for Translational Genomic Scholars. There are unprecedented opportunities to translate advances in genetics and genomics to clinical practice, and training geneticists in this area will be critical to bringing new approaches and discoveries to the clinic as quickly as possible," said Bruce R. Korf, MD, PhD, FACMG, President of the ACMG Foundation.

The ACMG Foundation for Genetic and Genomic Medicine (ACMGF) is a community of supporters and contributors who understand the importance of medical genetics and genomics in healthcare. A nonprofit organization established in 1992, the Foundation supports the American College of Medical Genetics and Genomics (ACMG) mission to "translate genes into health"; to foster charitable giving, promote training opportunities to attract future medical geneticists and genetic counselors, to share information about medical genetics, to sponsor important research and much more.

###

To learn more and support the ACMGF mission to create "Better Health through Genetics", please contact Nicole O. Bell, ACMG Foundation Manager at nbell@acmg.net or by phone at (301) 718-9604 or visit http://www.acmgfoundation.org.

Note to editors: To arrange interviews with experts in medical genetics, contact Kathy Moran, MBA, ACMG Senior Director of Communications and Public Relations at Kmoran@acmg.net or 301-238-4582.

To learn more about the ACMG Foundation for Genetic and Genomic Medicine visit http://www.acmgfoundation.org


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.